You just read:

Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody

News provided by

Sanofi and Regeneron Pharmaceuticals, Inc.

20 Jul, 2012, 06:00 BST